VEON reports Q1 2026 results on May 11 — five days out — and the setup is more sanguine than stressed, with options positioning turning notably constructive even as the stock drifts lower on the week.
The clearest signal this week is in options. The put/call ratio has fallen to 0.73, well below its 20-day average of 0.87, and nearly one standard deviation lower. That marks a significant reversal from where options traders stood just three weeks ago: through early-to-mid April the PCR was consistently running above 1.07, pointing to heavy demand for downside protection. That hedging activity has largely evaporated. The shift is notable given that the stock slipped 2.7% over the past week to close at $49.14, suggesting the options market is treating the dip as an opportunity rather than a warning. The 52-week PCR range runs from 0.55 to 3.07, so current positioning is far from extreme on either end — but the direction of travel is clearly more bullish.
Short interest tells a story of little conviction on either side. At just 0.26% of free float, there is barely a short position to speak of. The FINRA-reported figure pegs shares short at around 179,000 on a settlement date of April 15 — a rounding error for a stock of this profile. Short interest did tick up roughly 5% over the past month, driven by a modest step-up in mid-April, but the absolute level is too low to carry much signal. Borrowing costs reflect the same disinterest: cost to borrow runs at 0.49%, down 24% over the past month, and availability in the lending pool is vast. The ORTEX short score of 28.8 — ranking in the 74th percentile of all stocks for low short pressure — confirms the lending market is simply not engaged here. This is not a story about short sellers.
The valuation picture is cheap enough to be interesting. EV/EBITDA trades at approximately 3.0x on a trailing basis, a figure that ranks in the 98th percentile of the ORTEX universe on the EV/EBIT factor score — meaning VEON screens as one of the most attractively valued names in the database on an enterprise value basis. The P/E is around 6.2x, while the company's estimated annual revenue runs near $4.8 billion against an enterprise value of roughly $6.6 billion. Net debt of approximately $3.0 billion is the main offset to the headline cheapness, but the operational cash flow — estimated at $1.5 billion annually — provides meaningful cover. The EPS momentum factor score over 90 days comes in at 60, which is respectable, though the 30-day reading has slipped to 15, suggesting near-term estimate revisions have been modest at best.
The ownership structure is worth flagging, because it tells you a lot about why this stock trades the way it does. L1T VIP Holdings holds roughly 49% of shares — effectively a controlling stake. Lingotto Investment Management and Stichting Administratiekantoor Mobile Telecommunications Investor together account for another 17%. That leaves a thin free float, which in turn makes the options market and short interest figures harder to interpret at face value. CEO Muhterem Terzioglu held 1.1% of shares as of the last filing, a position that grew materially through a stock award in 2024 — though no open-market purchases are visible in the recent data, and insider filing data has not been updated since September 2024.
The earnings history adds one useful reference point. The most recent comparable event — a Q4/full-year update in March 2026 — produced a one-day gain of nearly 14% and a five-day gain of 11%. The prior event, in March 2026 at a different announcement, saw a one-day decline of just over 1% followed by a five-day loss near 6%. The range of outcomes is wide, which is consistent with a thin-float, concentrated-ownership stock where a single large holder's reaction can move prices materially. The next print on May 11 therefore sits against a backdrop where options traders have been steadily unwinding their hedges for the past two weeks — the question is whether Q1 numbers give them reason to rebuild them.
See the live data behind this article on ORTEX.
Open VEON on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
